InvestorsHub Logo
Followers 55
Posts 13532
Boards Moderated 0
Alias Born 10/12/2006

Re: LocWolf post# 11166

Monday, 11/21/2016 10:49:29 PM

Monday, November 21, 2016 10:49:29 PM

Post# of 18268
Either I'm reading this wrong, or management still believes that Neogenomics uses SVM in it's prostate test. From latest 10Q.

Plasma Test for Prostate Cancer

NeoGenomics is developing a Blood Test for Prostate Cancer under the direction of Dr. Maher Albitar using the genes patented by HDC. The test is performed on blood plasma and urine rather than only prostate tissue biopsies. NeoGenomics completed Phase I of their research and published the results in 2014. Additionally, NeoGenomics completed Phase II of their prostate test validation in 2014. The results were largely the same as those published regarding Phase I. NeoGenomics continues working on this test, named NeoLAB™ Prostate – Liquid Alternative to Biopsy. Per the license agreement, any commercial use of the NeoLAB™ Prostate Test by NeoGenomics will require compensation to HDC.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HDVY News